Indications for intravenous immunoglobulins;Immunoglobulines intraveineuses: Indications actuelles et perspectives

Presse Medicale

Volumn 35, Issue 4 II, 2006, Pages 714-719

  Mouthon, Luc ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Institut Cochin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; DAPSONE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE;

ALLOIMMUNITY; ALLOIMMUNIZATION; AUTOIMMUNE DISEASE; BACTERIAL INFECTION; BLOOD DONOR; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CLINICAL TRIAL; DRUG EFFICACY; GUILLAIN BARRE SYNDROME; HEMODIALYSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOMODULATION; INFLAMMATORY DISEASE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MUCOUS MEMBRANE PEMPHIGOID; MYASTHENIA GRAVIS; REVIEW; SEPTIC SHOCK; STREPTOCOCCUS INFECTION; TREATMENT INDICATION; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BULLOUS PEMPHIGOID; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FORECASTING; IMMUNOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RENAL REPLACEMENT THERAPY; TIME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AUTOIMMUNE DISEASES; FORECASTING; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MUCOCUTANEOUS LYMPH NODE SYNDROME; PEMPHIGOID, BULLOUS; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; RENAL DIALYSIS; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; TIME FACTORS;

EID: 33646927538     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0755-4982(06)74668-1     Document Type: Article

References (20)

1. Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981; 1: 1228-31.
2. Pirofsky B. Intravenous immune globulin therapy in hypogammaglobulinemia. Am J Med. 1984; 76: 53-60.
3. Eijkhout HW, van Der Meer JW, Kallenberg CG, Weening RS, van Dissel JT, Sanders LA et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial. Ann Intern Med. 2001; 135: 165-74.
4. Chapel H, Lee M, Hargreaves R, Pamphilon DH, Prentice AG. Randomised trial of imtravenous immunoglobulin as prophylaxis against infection in plateau-phase multiple myeloma. Lancet. 1994; 343: 1059-63.
5. Griffiths H, Brennen V, Lea J, Bunch C, Lee M, Chapel H. Crossover study of immunoglobulin replacement therapy in patients with low-grade B-cell tumors. Blood. 1989; 73: 366-8.
6. Sullivan KM, Kopecky KG, Jocom J, Fischer L, Buckner CD, Meyers JD et al. Immunomodulatory and anti-microbial efficacy of intravenous immunoglobulin in bone marrow transplantation. N Eng J Med. 1990; 323: 705-9.
7. Winston DJ, Antin JH, Wolff SN, Bierer BE, Small T, Miller KB et al. A multicenter, randomized, double-blind comparison of different doses of intravenous immunoglobulin for prevention of graft-versus-host disease and infection after allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001; 28: 187-96.
8. Cordonnier C, Chevret S, Legrand M, Rafi H, Dhedin N, Lehmann B et al. Should immunoglobulin therapy be used in allogeneic stem-cell transplantation? A randomized, double-blind, dose effect, placebo-controlled, multicenter trial. Ann Intern Med. 2003; 139: 8-18.
9. Godeau B, Chevret S, Varet B, Lefrere F, Zini JM, Bassompierre F et al. Intravenous immunoglobulin or high-dose methylprednisolone, with or without oral prednisone, for adults with untreated severe autoimmune thrombocytopenic purpura: a randomised, multicentre trial. Lancet. 2002; 359: 23-9.
10. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE et al. The treatment of Kawasaki syndrome with intravenous gammaglobulin. N Engl J Med. 1986; 315: 341-7.
11. Newburger JW, Takahashi M, Beiser AS, Burns JC, Bastian J, Chung KJ et al. A single intravenous infusion of gammaglobulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med. 1991; 324: 1633-9.
12. van der Meché FGA, Smith PIM, Dutch Guillain-Barré Study Group. A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. N Engl J Med. 1992; 326: 1123-9.
13. Gajdos P, Chevret S, Clair B, Tranchant C, Chastang C. Clinical trial of plasma exchange and high-dose intravenous immunoglobulin in myasthenia gravis. Myasthenia Gravis Study Group. Ann Neurol. 1997; 41: 789-96.
14. Van Schaik IN, Winer JB, De Haan R, Vermeulen M. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy. Cochrane Database Syst Rev. 2002: CD001797.
15. Jayne DR, Chapel H, Adu D, Misbah S, O'Donoghue D, Scott D et al. Intravenous immunoglobulin for ANCA-associated systemic vasculitis with persistent disease activity. QJM. 2000; 93: 433-9.
16. Martinez V, Cohen P, Mouthon E, Guillevin E, French vasculitis Study group. Intravenous immunoglobulins (IVIg) for relapses of ANCA-associated systemic vasculitides: final analysis of a prospective, open and multicenter trial. Arthritis Rheum. 2005; 52: S649.
17. Letko E, Miserocchi E, Daoud YJ, Christen W, Foster CS, Ahmed AR. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol. 2004; 111: 303-10.
18. Glotz D, Antoine C, Julia P, Suberbielle-Boissel C, Boudjeltia S, Fraoui R et al. Desensitization and subsequent kidney transplantation of patients using intravenous immunoglobulins (IVIg). Am J Transplant. 2002; 2: 758-60.
19. Mahmoud K, Sobh M, El-Shenawy F, Mostafa A, Abo El Magd M, Hassan N et al. Effect of high-dose intravenous immunoglobulin on suppression of alloantibodies against hla in highly sensitized transplant candidates. Transplant Proc. 2004; 36: 1850-2.
20. Darenberg J, Ihendyane N, Sjolin J, Aufwerber E, Haidl S, Follin P et al. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003; 37: 333-40.